| Autor: |
Han, Jessy Xinyi, Koh, Min Jung, Boussi, Leora, Sorial, Mark, McCabe, Sean M., Peng, Luke, Singh, Shambhavi, Eche-Ugwu, Ijeoma Julie, Gabler, Judith, Fernandez Turizo, Maria J., MacVicar, Caroline T., Garg, Aditya, Disciullo, Alexander, Chopra, Kusha, Lenart, Alexandra, Nwodo, Emmanuel, Barnes, Jeffrey, Koh, Min Ji, Miranda, Eliana, Chiattone, Carlos, Stuver, Robert, Horwitz, Steven M., Merrill, Mwanasha, Jacobsen, Eric, Manni, Martina, Civallero, Monica, Skrypets, Tetiana, Lymboussaki, Athina, Federico, Massimo, Kim, Yuri, Kim, Jin Seok, Cho, Jae Yong, Eipe, Thomas, Shet, Tanuja, Sridhar, Epari, Shetty, Alok, Saha, Saswata, Jain, Hasmukh, Sengar, Manju, Van Der Weyden, Carrie, Prince, Henry Miles, Hamouche, Ramzi, Murdashvili, Tinatin, Foss, Francine, Gentilini, Marianna, Casadei, Beatrice, Zinzani, Pier Luigi, Okatani, Takeshi, Yoshida, Noriaki, Yoon, Sang Eun, Kim, Won-Seog, Panchoo, Girisha, Mohamed, Zainab, Verburgh, Estelle, Alturas, Jackielyn Cuenca, Al-Mansour, Mubarak, Ford, Josie, Cabrera, Maria Elena, Ku, Amy, Bhagat, Govind, Ma, Helen, Sawas, Ahmed, Kariya, Khyati Maulik, Iwasaki, Makoto, Bhanushali, Forum, O’Connor, Owen A., Marchi, Enrica, Shen, Changyu, Shah, Devavrat, Jain, Salvia |
| Zdroj: |
Blood Advances; 20240101, Issue: Preprints |
| Abstrakt: |
⁃PIRT is a novel prognostic model for patients with R/R mature T-cell and NK-cell lymphomas that defined risk groups with differing outcomes.⁃Small molecule inhibitors offer survival advantage relative to chemotherapy in AITL warranting continued investigation in clinical trials. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
